Revolax vs Juvederm – Comparing Fillers

Last Updated On: October 29, 2024

According to the American Society of Plastic Surgeons (ASPS), the popularity of dermal filler procedures has seen significant growth, with millions performed annually. Dermal fillers are among the top minimally invasive cosmetic treatments chosen by many to reduce wrinkles, restore volume, and enhance facial contours.

Two leading fillers in this category are Revolax and Juvederm, both known for their effectiveness. Revolax is celebrated for its smooth consistency and ability to add volume, while Juvederm offers a variety of formulations designed to target specific facial areas. Understanding the differences between these two can help you make the right choice for your aesthetic goals.

In this article, we’ll compare Revolax and Juvederm and explore their benefits, application processes, and patient outcomes to help you decide which filler is best for you.

Key Takeaways

• Revolax and Juvederm are popular dermal fillers to enhance facial features and reduce signs of aging.
• Revolax is known for its smooth texture, affordability, and long-lasting results, often up to 24 months. It adds volume to the cheeks, lips, and nasolabial folds.
• Juvederm, produced by Allergan, uses Vycross technology for a smooth, natural look. Depending on the formulation, its results typically last 12 to 18 months. It’s popular for smoothing wrinkles and enhancing facial contours.
• Revolax tends to be a more cost-effective option, while Juvederm’s reputation and consistent outcomes justify its higher price.
• Both fillers are effective, with Revolax ideal for volume and Juvederm excelling in areas requiring a smoother, more fluid application.
• The choice between the two depends on your aesthetic goals, budget, and treatment area.

About: Operating since 2016, Med Supply Solutions is known for being one of the industry’s top and trusted suppliers of cosmetic and viscosupplementation products. If you’re looking to buy Revolax online, contact our sales department for more information.

Introduction to Revolax and Juvederm

Revolax and Juvederm are two of the most popular dermal fillers used to refresh the skin and restore volume. 

Revolax, developed in South Korea, is loved for its smooth texture and ability to enhance areas like the cheeks, lips, and nasolabial folds. Plus, its effects can last up to 24 months, making it a long-lasting choice for many.

On the other hand, Juvederm is produced by Allergan and uses Vycross technology to deliver long-lasting, natural-looking results. It’s especially effective for smoothing wrinkles and adding fullness, and it’s trusted worldwide for its reliable performance.

Formulation and Consistency

Revolax and Juvederm are both popular dermal fillers, but they have some key differences in how they feel and work under the skin.

Revolax has a thicker, gel-like consistency, which makes it great for adding volume to areas like the cheeks, lips, and nasolabial folds. It’s made with high-quality hyaluronic acid, giving it a natural feel, and its effects can last up to 24 months.

Juvederm is known for its smoother texture. Thanks to its Vycross technology, which combines different molecular weights of hyaluronic acid, it flows easily into the skin and blends seamlessly, delivering natural-looking results. Juvederm also helps hydrate the skin by attracting moisture, which gives the treated areas a plumper, refreshed look.

Both fillers work well, but Revolax is often chosen for adding volume, while Juvederm is loved for its smooth application and consistent, natural results. The right choice depends on your personal preferences and the look you’re going for.

Longevity and Effectiveness

Revolax fillers typically last between 8 to 24 months, depending on the specific product used and the treatment area. As for Juvederm fillers, they generally last between 6 to 24 months, with some formulations lasting up to 12 months.

Effectiveness of Revolax and Juvederm

Both Revolax and Juvederm are effective in treating various areas of the face:

• Lips: Both fillers are popular for lip augmentation. Revolax provides a fuller, more structured look, while Juvederm offers a softer, more natural result.
• Nasolabial Folds: Both fillers are effective in reducing the appearance of nasolabial folds, with Juvederm showing significant correction maintained after 24 weeks in studies.
• Tear Troughs: Juvederm is often used to address under-eye hollows, providing a smoother transition from the lower eyelid to the cheek.

When comparing the effectiveness of Revolax and Juvederm, both fillers demonstrate non-inferiority in volumizing effects across various areas such as the midface, temple, jawline, and chin. However, Revolax is noted for its longer-lasting results and fewer acute side effects compared to Juvederm Voluma.

Pricing and Patient Satisfaction

When it comes to pricing, both Revolax and Juvederm offer competitive rates, but there are some differences to consider:

• Revolax: The cost of Revolax fillers can vary depending on the specific product and the region, but they generally range from $400 to $800 per syringe. Their longevity often makes them a cost-effective option in the long run.
• Juvederm: Juvederm fillers also vary in price based on the specific formulation and location, typically ranging from $500 to $900 per syringe. Some formulations, like Juvederm Voluma, may be on the higher end of the price spectrum due to their specialized use.

Despite the price differences, patient satisfaction remains high for both fillers. Users appreciate the natural results and longevity offered by each option. Many positive Revolax filler reviews emphasize its effectiveness in beautifully enhancing facial features, further solidifying its popularity among those seeking aesthetic treatments.

On Revolax

Image courtesy of VisoManchester

This patient underwent treatment with 1.1ml of Revolax Deep for lip enhancement, achieving a gorgeous result. Her stunning nails add an elegant touch to her overall appearance.

On Juvederm

Image courtesy of ReNu Medical & Spa

This patient received JUVEDERM® VOLUX® XC, the first FDA-approved HA filler for enhancing jawline definition. The before-and-after results showcase remarkable improvements with lasting effects.

Juvederm offers a noteworthy combination of endurance, safety, diversity, and immediate outcomes that captivates recipients and healthcare professionals.

Conclusion

Choosing between Revolax and Juvederm comes down to your personal needs and goals. Revolax is loved for its smooth texture and affordability, while Juvederm is a trusted choice for its consistency and natural results. Both fillers deliver long-lasting effects, but the right one for you depends on the look you want to achieve and your budget.

The best way to decide is to consult with your doctor, who can help guide you to the perfect option for your aesthetic goals.

FAQs

1. What are Revolax and Juvederm, and how do they compare?

Revolax and Juvederm are both popular fillers used to enhance lips or smooth tear troughs. However, they differ in their FDA approval status, side effects, and user reviews.

2. Is Revolax approved by the FDA?

As of now, Revolax is not FDA-approved. However, many users have given positive reviews about its use on lips and fine lines around the eyes.

3. Are there any side effects associated with using Revolax?

Like all fillers, potential side effects can occur with Revolax use, such as redness or swelling at the injection site, which usually subsides within a few days.

References

2023 Plastic surgery statistics. American Society of Plastic Surgeons. https://www.plasticsurgery.org/news/plastic-surgery-statistics

Master M, Azizeddin A, Master V. Hyaluronic acid filler longevity in the mid-face: A review of 33 magnetic resonance imaging studies. Plastic & Reconstructive Surgery Global Open. 2024;12(7):e5934. doi:10.1097/gox.0000000000005934

Pinsky M, Thomas J, Murphy D, Walker P. Juvéderm injectable gel: A multicenter, double-blind, randomized study of safety and effectiveness. Aesthetic Surgery Journal. 2008;28(1):17-23. doi:10.1016/j.asj.2007.09.005